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[16 Abstract / Annals of Physical and Reh
unctional hand”. The high rate of intrinsic deformations, unmasked by the iso-
ated relaxation of the extrinsic muscles, incites us to use preoperative screening
ith motor blocks.
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ntrathecal baclofen in cerebral palsy. A retrospective
tudy of 25 wheelchair-assisted adults
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bjective.– To study efficacity and tolerance of intrathecal baclofen (ITB) in
heelchair-dependent adults with cerebral palsy.
atients and methods.– Retrospective analysis and clinical examination of 25
heelchair-dependent adults with cerebral palsy implanted for ITB treatment
etween 1999 and 2009 in the west of France.
esults.– Intratecal baclofen improved spasticity and facilitated sitting and nur-
ing. There was an effect of ITB on motor disorders and pain. 80% of patients
ith BIT were satisfied; the others reported side effects rather than the absence of
ffect. Complications occurred in 32% of patients and requiring discontinuation
r pump removal in 16%.
onclusions.– Development of ITB in this indication is probable and warrants
etter understanding of the pharmacological effect on movement disorders and
ain. The use of Goal Attainment Scale (GAS) and of Caregiver Questionnaire
ould be helpful for evaluating the efficiency of ITB.
oi:10.1016/j.rehab.2011.07.912
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ntroduction.– The incidence of hip dislocations in cerebral palsy is significant
1], requiring prevention, including botulinum toxin injections [2] from child-
ood. Hip dislocation may be diagnosed with delay, causing persistent pain.
ntra-articular corticosteroid hip injections may temporarily relieve pain and
elay surgery.
bservation.– In University Hospital of Montpellier, from July 2009 to January
011, four non-walking patients with cerebral palsy, 15 to 25 years old, with
nilateral hip dislocation, had intra-articular hip corticosteroids with local anaes-
hesic injections for three of them. Patients 1, 2 and 3 had botulinum toxin
njections in periarticular muscles in the same time.
s
a
1tation Medicine 54S (2011) e12–e18
esults.– For patient 1, injection of corticosteroids resulted in total pain relief
t 48 hours lasting 3 months (hetero assessment, pain VAS impossible), the
ntervention was repeated three times. Regarding temporary benefit and severe
ain, the patient had a soft-tissue surgery of the hip 3 months after the last
njection.
or patient 2, injection of corticosteroids resulted in a decrease in pain imme-
iately after the intervention and for 1 month (hetero assessment, pain VAS
mpossible). He then had a femoral valgisation osteotomy 4 months later.
or patient 3, one first injection was effective on pain, so repeated 5 months later
ith long-lasting effect and no need for surgery.
or patient 4, the injection was inefficient (pre-injection VAS 70/100 and imme-
iately post-injection 60/100, at 2 months 70/100). Due to the severity of pain
nd grade IV chondropathy on scan imaging, hip arthroplasty was proposed.
iscussion.– Corticosteroids associated with an anaesthesic test may have diag-
ostic and therapeutic value, achieving pain relief for three patients which lasted
everal weeks. Injections may result in a decrease in osteoarticular pain, while
otulinum toxin has an effect on the muscular component of pain. This type of
ntervention is not described in the literature for cerebral palsy adult patients.
onclusion.– Intra-articular hip injections of corticosteroids may result in tem-
orary pain relief and delay possible surgery.
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he timing of surgery with regard to recurrence risk after neurological Hete-
otopic Ossification (HO) excision is still debated. This study investigated the
ssociation between recurrence risk after HO excision in Traumatic Brain Injury
TBI) patients and [1] the operative delay and [2] the degree of neurological
equellae (Garland status).
case control study was performed. Patients who developed troublesome HO
equiring surgery after TBI with (case, n = 16) or without recurrence (control,
= 64) were retrospectively included. Other matching criteria were: sex and age
t the time of surgery (± 4 years).
he median delay for first HO surgery was 13.7 months (IQR 9.0 to 37.1) for the
ase group and 13.2 months (IQR 7.8 to 30.0) for the control group. No signi-
cant link was found between recurrence and operative delay (P = 0.54), even
fter inclusion of all matching factors (P = 0.53) or Garland status (P = 0.81). The
nclusion of Garland status into the model did not change this result (P = 0.64).
fter TBI, no link was found between HO operative delay and recurrence. In
pite of a common notion of a relationship between initial severity of TBI and
O development, no link was found between HO recurrence risk and the severity
f sequellae.
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